Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus

Carlo Bellini, Francesco Campone, Giovanni Serra

Research output: Contribution to journalArticlepeer-review

Abstract

Patent ductus arteriosus is one of the most common congenital abnormalities found in premature infants. Ibuprofen, a nonsteroidal drug that is commonly used as an antipyretic, analgesic and anti-inflammatory agent, is also used to induce closure of symptomatic patent ductus arteriosus in preterm infants. Recently, we gave L-lysine ibuprofen to a preterm infant with respiratory distress to induce closure of a patent ductus arteriosus, and the infant experienced pulmonary hypertension. Only 3 cases of pulmonary hypertension following early administration of an ibuprofen solution buffered with tromethamine have previously been reported. However, this severe side effect has never been observed in multicentre, randomized, double-blind controlled trials, nor in recent reviews or meta-analyses of L-lysine ibuprofen use.

Original languageEnglish
Pages (from-to)1843-1844
Number of pages2
JournalCMAJ
Volume174
Issue number13
DOIs
Publication statusPublished - Jun 20 2006

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus'. Together they form a unique fingerprint.

Cite this